KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in KalVista Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- −8 vs. Q3 2023
- Shares held
- 37.0M
- +719.8K (+2.0%) vs. Q3 2023
- Total value
- $453.0M
- +$103.8M (+29.7%) vs. Q3 2023
- New holders
- 14
- 46 more added
- Sold out
- 22
- 22 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $189 |
| Q1 2026 | 184 | $1.39B |
| Q4 2025 | 162 | $1.08B |
| Q3 2025 | 145 | $714.0M |
| Q2 2025 | 140 | $615.5M |
| Q1 2025 | 128 | $633.7M |
| Q4 2024 | 130 | $467.4M |
| Q3 2024 | 122 | $561.0M |
| Q2 2024 | 119 | $568.2M |
| Q1 2024 | 129 | $557.2M |
| Q4 2023 | 93 | $453.0M |
| Q3 2023 | 101 | $349.2M |
| Q2 2023 | 94 | $310.1M |
| Q1 2023 | 88 | $265.0M |
| Q4 2022 | 91 | $236.2M |
| Q3 2022 | 94 | $372.0M |
| Q2 2022 | 91 | $238.7M |
| Q1 2022 | 89 | $363.9M |
| Q4 2021 | 97 | $314.6M |
| Q3 2021 | 105 | $408.2M |
| Q2 2021 | 110 | $582.7M |
| Q1 2021 | 117 | $605.1M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −34,393−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −30,790−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −25,338−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −23,250−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −22,941−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −13,955−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −10,807−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,738−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −8,810−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,200−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |